4min chapter

ACR on Air cover image

33. B-Cell Depleting Therapies and COVID-19

ACR on Air

CHAPTER

The Importance of German Center Responses in the Treatment of Lupus

The development of Everschield and Pax-Lovid has really made me feel a little bit better about giving me some depressive drugs to our patients. I think specific, I'm so anchored in vaccine responses now. What have you learned about either B cells or our use of vaccines that can maybe improve the way that we manage our patients going forward? The question here is about, if you happen to hold medicines for optimizing acute antibody responses, when you restarted these GC responses are obviously still ongoing. Is that going to reduce antibody quality? Right.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode